Join
Live feed
·
INSIDERFilingvia Quantisnow
TherapeuticsMD Inc. logo

Director Collins Cooper C. bought $2,039 worth of shares (1,200 units at $1.70), increasing direct ownership by 3% to 47,922 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
TXMD· TherapeuticsMD Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TXMD (TherapeuticsMD Inc.) and more on Quantisnow.